Takanori Ogawa Selected Research

Meropenem (Merrem)

1/2021	Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients.
1/2021	Reply to Béranger et al., "Integration of Continuous Renal Replacement Therapy in a Meropenem Population Pharmacokinetics Model in Critically Ill Children".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takanori Ogawa Research Topics

Disease

2	Critical Illness (Critically Ill) 01/2021 - 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Lung Neoplasms (Lung Cancer) 11/2019
1	Neutropenia 11/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Myocardial Infarction 01/2018
1	Aortic Dissection 11/2014

Drug/Important Bio-Agent (IBA)

2	Meropenem (Merrem)FDA LinkGeneric 01/2021 - 01/2021
1	amrubicinolIBA 11/2019
1	PlatinumIBA 11/2019
1	amrubicinIBA 11/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	pitavastatin (itavastatin)FDA Link 01/2018
1	LDL CholesterolIBA 01/2018
1	resorcinol (resorcin)IBA 11/2014
1	Formaldehyde (Formol)FDA Link 11/2014
1	GelatinIBA 11/2014

Therapy/Procedure

2	Continuous Renal Replacement Therapy 01/2021 - 01/2021
1	Extracorporeal Membrane Oxygenation 01/2021
1	Drug Therapy (Chemotherapy) 11/2019
1	Therapeutics 01/2018